Poteligeo 20 MG/5 ML vial 5ML
Ended Awarded
- Contract number
- SPE2DB25FYX48
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,246
Award facts
- Contract value 100% obligated
- $41,246.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of Poteligeo 20 mg/5 ml vials. The contract is valued at $41,246.04 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 24, 2025. This award was issued without a set-aside designation, demonstrating the company's competitive strength in federal pharmaceutical procurement. The performance location is Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at $499,999,999 and remains valid through November 2026. The IDC enables the DLA to procure a comprehensive range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with a consistent portfolio of contract awards covering branded and generic prescription drugs, biologics, and medical consumables. Poteligeo, a specialized pharmaceutical product, exemplifies the company's role in distributing advanced medications to military health facilities.
Quick answers
Who was awarded contract SPE2DB25FYX48?
SPE2DB25FYX48 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FYX48 worth?
The government has obligated $41,246 on SPE2DB25FYX48.
Is contract SPE2DB25FYX48 an order under another contract?
Yes. SPE2DB25FYX48 is a delivery order under SPE2DB22D9133, an indefinite delivery contract.
Was contract SPE2DB25FYX48 competed?
The extent of competition for SPE2DB25FYX48 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award